Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus

Critical Reviews in Oncology/Hematology

Volumn 96, Issue 2, 2015, Pages 372-384

  Schindler, Antonio ^a   Denaro, Nerina ^b   Russi, Elvio G ^c   Pizzorni, Nicole ^a   Bossi, Paolo ^d   Merlotti, Anna ^e   Spadola Bissetti, Massimo ^f   Numico, Gianmauro ^g   Gava, Alessandro ^h   Orlandi, Ester ^d   Caspiani, Orietta ⁱ   Buglione, Michela ^j   Alterio, Daniela ^k   Bacigalupo, Almalina ^l   De Sanctis, Vitaliana ^m   Pavanato, Giovanni ⁿ   Ripamonti, Carla ^d   Merlano, Marco C ^b   Licitra, Lisa ^e   Sanguineti, Giuseppe ^o   Langendijk, Johannes A ^p   Murphy, Barbara ^q   more..

^a UNIVERSITY OF MILAN   (Italy)

^b Medical Oncology   (Italy)

^c AO S Croce e Carle Cuneo ^*  (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e OSPEDALE DI CIRCOLO   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g SC Geriatria   (Italy)

^h TREVISO REGIONAL HOSPITAL   (Italy)

ⁱ FATEBENEFRATELLI HOSPITAL   (Italy)

^j UNIVERSITY OF BRESCIA   (Italy)

^k EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^l UNIVERSITY OF GENOA   (Italy)

^m SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁿ Ospedale Santa Maria della Misericordia   (Italy)

^o REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^p UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^q VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Chemotherapy; Deglutition; Dysphagia; Head and neck cancer; Radiation oncology; Radiotherapy; Swallowing dysfunction

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DELPHI STUDY; DYSPHAGIA; FIBERSCOPE ENDOSCOPY; FLUOROGRAPHY; HEAD AND NECK CANCER; HUMAN; OUTCOME ASSESSMENT; RATING SCALE; REVIEW; RISK FACTOR; SIMULATION; SWALLOWING; ADVERSE EFFECTS; CONSENSUS DEVELOPMENT; DEGLUTITION DISORDERS; HEAD AND NECK NEOPLASMS; RADIOTHERAPY;

DEGLUTITION DISORDERS; DELPHI TECHNIQUE; HEAD AND NECK NEOPLASMS; HUMANS; RADIOTHERAPY;

EID: 84955199031     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2015.06.005     Document Type: Review

References (105)

1. Caudell J.J., Schaner P.E., Meredith R.F., Locher J.L., Nabell L.M., Carroll W.R., et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int. J. Radiat. Oncol. 2009, 73:410-415. 10.1016/j.ijrobp.2008.04.048.
2. Machtay M., Moughan J., Trotti A., Garden A.S., Weber R.S., Cooper J.S., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J. Clin. Oncol. 2008, 26:3582-3589. 10.1200/JCO.2007.14.8841.
3. Russi E.G., Corvò R., Merlotti A., Alterio D., Franco P., Pergolizzi S., et al. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treat. Rev. 2012, 38:1033-1049. 10.1016/j.ctrv.2012.04.002.
4. Mirabile A., Numico G., Russi E.G., Bossi P., Crippa F., Bacigalupo A., et al. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: literature review and consensus. Crit. Rev. Oncol. Hematol. 2015, 10.1016/j.critrevonc.2015.03.003.
5. Nguyen N.P., Moltz C.C., Frank C., Vos P., Smith H.J., Karlsson U., et al. Evolution of chronic dysphagia following treatment for head and neck cancer. Oral Oncol. 2006, 42:374-380. 10.1016/j.oraloncology.2005.09.003.
6. Hutcheson K.A., Lewin J.S., Barringer D.A., Lisec A., Gunn G.B., Moore M.W.S., et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer 2012, 118:5793-5799. 10.1002/cncr.27631.
7. Eisbruch A., Lyden T., Bradford C.R., Dawson L.A., Haxer M.J., Miller A.E., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int. J. Radiat. Oncol. 2002, 53:23-28. 10.1016/S0360-3016(02)02712-8.
8. Van der Molen L., van Rossum M., Ackerstaff A., Smeele L., Rasch C., Hilgers F. Pretreatment organ function in patients with advanced head and neck cancer: clinical outcome measures and patients' views. BMC Ear Nose Throat Disord. 2009, 9:10. 10.1186/1472-6815-9-10.
9. Feng F.Y., Kim H.M., Lyden T.H., Haxer M.J., Worden F.P., Feng M., et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J. Clin. Oncol. 2010, 28:2732-2738. 10.1200/JCO.2009.24.6199.
10. Cartmill B., Cornwell P., Ward E., Davidson W., Nund R., Bettington C., et al. Emerging understanding of dosimetric factors impacting on dysphagia and nutrition following radiotherapy for oropharyngeal cancer. Head Neck 2012, 10.1002/hed.23040.
11. Pauloski B.R., Rademaker A.W., Logemann J.A., Stein D., Beery Q., Newman L., et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck 2000, 22:474-482.
12. Langerman A., MacCracken E., Kasza K., Haraf D.J., Vokes E.E., Stenson K.M. Aspiration in chemoradiated patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 2007, 133:1289-1295. 10.1001/archotol.133.12.1289.
13. Denaro N., Merlano M.C., Russi E.G. Dysphagia in head and neck cancer patients: pretreatment evaluation, predictive factors, and assessment during radio-chemotherapy, recommendations. Clin. Exp. Otorhinolaryngol. 2013, 6:117-126. 10.3342/ceo.2013.6.3.117.
14. Kendall K.A., McKenzie S.W., Leonard R.J., Jones C. Structural mobility in deglutition after single modality treatment of head and neck carcinomas with radiotherapy. Head Neck 1998, 20:720-725. 10.1002/(SICI)1097-0347(199812)20:8<720::AID-HED10>3.0.CO;2-L.
15. Eisbruch A., Schwartz M., Rasch C., Vineberg K., Damen E., Van As C.J., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int. J. Radiat. Oncol. 2004, 60:1425-1439. 10.1016/j.ijrobp.2004.05.050.
16. Nutting C.M., Morden J.P., Harrington K.J., Urbano T.G., Bhide S.A., Clark C., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011, 12:127-136. 10.1016/S1470-2045(10)70290-4.
17. Little M., Schipper M., Feng F.Y., Vineberg K., Cornwall C., Murdoch-Kinch C.-A., et al. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands. Int. J. Radiat. Oncol. 2012, 83:1007-1014. 10.1016/j.ijrobp.2011.09.004.
18. Bremer M., Klöpper K., Yamini P., Bendix-Waltes R., Dörk T., Karstens J.H. Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects. Radiother. Oncol. 2003, 69:155-160. 10.1016/j.radonc.2003.08.004.
19. Iannuzzi C.M., Atencio D.P., Green S., Stock R.G., Rosenstein B.S. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int. J. Radiat. Oncol. Biol. Phys. 2002, 52:606-613.
20. Brown T., Ross L., Jones L., Hughes B., Banks M. Nutrition outcomes following implementation of validated swallowing and nutrition guidelines for patients with head and neck cancer. Support. Care Cancer 2014, 1-11. 10.1007/s00520-014-2180-9.
21. Xanthoulea S., Deliaert A., Romano A., Rensen S.S., Buurman W.A., van der Hulst R.R.W.J. Nicotine effect on inflammatory and growth factor responses in murine cutaneous wound healing. Int. Immunopharmacol. 2013, 17:1155-1164. 10.1016/j.intimp.2013.10.022.
22. McMaster S.K., Paul-Clark M.J., Walters M., Fleet M., Anandarajah J., Sriskandan S., et al. Cigarette smoke inhibits macrophage sensing of Gram-negative bacteria and lipopolysaccharide: relative roles of nicotine and oxidant stress. Br. J. Pharmacol. 2008, 153:536-543. 10.1038/sj.bjp.0707595.
23. Langendijk J.A., Doornaert P., Verdonck-de Leeuw I.M., Leemans C.R., Aaronson N.K., Slotman B.J. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J. Clin. Oncol. 2008, 26:3770-3776. 10.1200/JCO.2007.14.6647.
24. Teguh D.N., Levendag P.C., Voet P., van der Est H., Noever I., de Kruijf W., et al. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck 2008, 30:622-630. 10.1002/hed.20760.
25. Van der Molen L., Heemsbergen W.D., de Jong R., van Rossum M.A., Smeele L.E., Rasch C.R.N., et al. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother. Oncol. 2013, 106:364-369. 10.1016/j.radonc.2013.03.005.
26. Deasy J.O., Moiseenko V., Marks L., Chao K.S.C., Nam J., Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int. J. Radiat. Oncol. 2010, 76:S58-S63. 10.1016/j.ijrobp.2009.06.090.
27. Roe J.W.G., Carding P.N., Dwivedi R.C., Kazi R.A., Rhys-Evans P.H., Harrington K.J., et al. Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head and neck cancer - a systematic review. Oral Oncol. 2010, 46:727-733. 10.1016/j.oraloncology.2010.07.012.
28. Van der Laan H.P., Christianen M.E.M.C., Bijl H.P., Schilstra C., Langendijk J.A. The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: an in silico planning comparative study. Radiother. Oncol. 2011, 10.1016/j.radonc.2011.11.001.
29. Carroll W.R., Locher J.L., Canon C.L., Bohannon I.A., McColloch N.L., Magnuson J.S. Pretreatment swallowing exercises improve swallow function after chemoradiation. The Laryngoscope 2008, 118:39-43. 10.1097/MLG.0b013e31815659b0.
30. Kulbersh B.D., Rosenthal E.L., McGrew B.M., Duncan R.D., McColloch N.L., Carroll W.R., et al. Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. The Laryngoscope 2006, 116:883-886. 10.1097/01.mlg.0000217278.96901.fc.
31. Cnossen I.C., van Uden-Kraan C.F., Rinkel R.N., Aalders I.J., de Goede C.J.T., de Bree R., et al. Multimodal guided self-help exercise program to prevent speech, swallowing, and shoulder problems among head and neck cancer patients: a feasibility study. J. Med. Internet Res. 2014, 16:e74. 10.2196/jmir.2990.
32. Carnaby-Mann G., Crary M.A., Schmalfuss I., Amdur R. Pharyngocise: randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy. Int. J. Radiat. Oncol. 2012, 83:210-219. 10.1016/j.ijrobp.2011.06.1954.
33. Van der Molen L., van Rossum M.A., Burkhead L.M., Smeele L.E., Rasch C.R.N., Hilgers F.J.M. A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects. Dysphagia 2011, 26:155-170. 10.1007/s00455-010-9288-y.
34. Paleri V., Roe J.W.G., Strojan P., Corry J., Grégoire V., Hamoir M., et al. Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck 2014, 36:431-443. 10.1002/hed.23251.
35. Schindler O. Future perspectives in deglutology. Acta Otorhinolaryngol. Ital. 2007, 27:317-319.
36. Piemonte M. Presentation and aims of the Round Table. Acta Otorhinolaryngol. Ital. 2007, 27:275-276.
37. Loblaw D.A., Prestrud A.A., Somerfield M.R., Oliver T.K., Brouwers M.C., Nam R.K., et al. American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology. J. Clin. Oncol. 2012, 30:3136-3140. 10.1200/JCO.2012.42.0489.
38. National Cancer Institute Common Terminology Criteria for Adverse Events v. 4.0 2009.
39. Jensen K., Lambertsen K., Torkov P., Dahl M., Bonde Jensen A., Grau C. Patient assessed symptoms are poor predictors of objective findings: results from a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncol. 2007, 46:1159-1168. 10.1080/02841860701491041.
40. Bjordal K., Ahlner-Elmqvist M., Tollesson E., Jensen A.B., Razavi D., Maher E.J., et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients, EORTC Quality of Life Study Group. Acta Oncol. Stockh. Swed. 1994, 33:879-885.
41. List M.A., D'Antonio L.L., Cella D.F., Siston A., Mumby P., Haraf D., et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer 1996, 77:2294-2301. 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S.
42. Belafsky P.C., Mouadeb D.A., Rees C.J., Pryor J.C., Postma G.N., Allen J., et al. Validity and reliability of the Eating Assessment Tool (EAT-10). Ann. Otol. Rhinol. Laryngol. 2008, 117:919-924.
43. McHorney C.A., Martin-Harris B., Robbins J., Rosenbek J. Clinical validity of the SWAL-QOL and SWAL-CARE outcome tools with respect to bolus flow measures. Dysphagia 2006, 21:141-148. 10.1007/s00455-005-0026-9.
44. Rinkel R.N., Verdonck-de Leeuw I.M., Langendijk J.A., van Reij E.J., Aaronson N.K., René Leemans C. The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral Oncol. 2009, 45:e67-e71. 10.1016/j.oraloncology.2009.03.003.
45. Chen A.Y., Frankowski R., Bishop-Leone J., Hebert T., Leyk S., Lewin J., et al. the development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M D. Anderson Dysphagia Inventory. Arch. Otolaryngol. Head Neck Surg. 2001, 127:870-876. 10.1001/pubs.Arch Otolaryngol. Head Neck Surg.-ISSN-0886-4470-127-7-ooa00162.
46. Schindler A., Borghi E., Tiddia C., Ginocchio D., Felisati G., Ottaviani F. Adaptation and validation of the Italian MD Anderson Dysphagia Inventory (MDADI). Rev. Laryngol. Otol. Rhinol. 2008, 129:97-100.
47. Guedes R.L.V., Angelis E.C., Chen A.Y., Kowalski L.P., Vartanian J.G. Validation and application of the M.D. Anderson Dysphagia Inventory in patients treated for head and neck cancer in Brazil. Dysphagia 2013, 28:24-32. 10.1007/s00455-012-9409-x.
48. Carlsson S., Rydén A., Rudberg I., Bove M., Bergquist H., Finizia C. Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer and neurologic swallowing disturbances. Dysphagia 2012, 27:361-369. 10.1007/s00455-011-9375-8.
49. Chen A.Y., Frankowski R., Bishop-Leone J., et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson Dysphagia Inventory. Arch. Otolaryngol. Neck Surg. 2001, 127:870-876.
50. Colodny N. Effects of age, gender, disease, and multisystem involvement on oxygen saturation levels in dysphagic persons. Dysphagia 2001, 16:48-57.
51. Lim S.H., Lieu P.K., Phua S.Y., Seshadri R., Venketasubramanian N., Lee S.H., et al. Accuracy of bedside clinical methods compared with fiberoptic endoscopic examination of swallowing (FEES) in determining the risk of aspiration in acute stroke patients. Dysphagia 2001, 16:1-6.
52. Wakasugi Y., Tohara H., Hattori F., Motohashi Y., Nakane A., Goto S., et al. Screening test for silent aspiration at the bedside. Dysphagia 2008, 23:364-370. 10.1007/s00455-008-9150-7.
53. Murphy B.A. Approaches to supportive care. Head Neck Cancer Multimodality Management 2011, 255-266. Springer. J. Bernier (Ed.).
54. Agency for Health Care Policy and Research Diagnosis and Treatment of Swallowing Disorders (Dysphagia) in Acute-Care Stroke Patients - NCBI Bookshelf 1999, Agency for Health Care Policy and Research (USA), Washington, DC.
55. Smith Hammond C.A., Goldstein L.B. Cough and aspiration of food and liquids due to oral-pharyngeal dysphagia. Chest 2006, 129:154S-168S. 10.1378/chest.129.1_suppl.154S.
56. Bours G.J.J.W., Speyer R., Lemmens J., Limburg M., De Wit R. Bedside screening tests vs. videofluoroscopy or fibreoptic endoscopic evaluation of swallowing to detect dysphagia in patients with neurological disorders: systematic review. J. Adv. Nurs. 2009, 65:477-493. 10.1111/j.1365-2648.2008.04915.x.
57. Speyer R., Baijens L., Heijnen M., Zwijnenberg I. Effects of therapy in oropharyngeal dysphagia by speech and language therapists: a systematic review. Dysphagia 2009, 25:40-65. 10.1007/s00455-009-9239-7.
58. Kotz T., Federman A.D., Kao J., Milman L., Packer S., Lopez-Prieto C., et al. Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial. Arch Otolaryngol. Head Neck Surg. 2012, 138:376-382. 10.1001/archoto.2012.187.
59. Duarte V.M., Chhetri D.K., Liu Y.F., Erman A.A., Wang M.B. Swallow preservation exercises during chemoradiation therapy maintains swallow function. Otolaryngol. Head Neck Surg. 2013, 149:878-884. 10.1177/0194599813502310.
60. Van der Molen L., van Rossum M.A., Rasch C.R.N., Smeele L.E., Hilgers F.J.M. Two-year results of a prospective preventive swallowing rehabilitation trial in patients treated with chemoradiation for advanced head and neck cancer. Eur. Arch. Oto-Rhino-Laryngol. 2013, 10.1007/s00405-013-2640-8.
61. Aviv J.E. Prospective, randomized outcome study of endoscopy versus modified barium swallow in patients with dysphagia. The Laryngoscope 2000, 110:563-574. 10.1097/00005537-200004000-00008.
62. Rosen A., Rhee T.H., Kaufman R. Prediction of aspiration in patients with newly diagnosed untreated advanced head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 2001, 127:975-979. 10.1001/archotol.127.8.975.
63. Cousins N., MacAulay F., Lang H., MacGillivray S., Wells M. A systematic review of interventions for eating and drinking problems following treatment for head and neck cancer suggests a need to look beyond swallowing and trismus. Oral Oncol. 2013, 49:387-400. 10.1016/j.oraloncology.2012.12.002.
64. Starmer H., Gourin C., Lua L.L., Burkhead L. Pretreatment swallowing assessment in head and neck cancer patients. The Laryngoscope 2011, 121:1208-1211. 10.1002/lary.21800.
65. Starmer H.M. Dysphagia in head and neck cancer: prevention and treatment. Curr. Opin. Otolaryngol. Head Neck Surg. 2014, 22:195-200. 10.1097/MOO.0000000000000044.
66. Aviv J.E., Spitzer J., Cohen M., Ma G., Belafsky P., Close L.G. Laryngeal adductor reflex and pharyngeal squeeze as predictors of laryngeal penetration and aspiration. The Laryngoscope 2002, 112:338-341. 10.1097/00005537-200202000-00025.
67. Aviv J.E., Murry T., Zschommler A., Cohen M., Gartner C. Flexible endoscopic evaluation of swallowing with sensory testing: patient characteristics and analysis of safety in 1340 consecutive examinations. Ann. Otol. Rhinol. Laryngol. 2005, 114:173-176.
68. Langmore S.E. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior?. Curr. Opin. Otolaryngol. Head Neck Surg. 2003, 11:485-489.
69. Kotz T., Costello R., Li Y., Posner M.R. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 2004, 26:365-372. 10.1002/hed.10385.
70. Servagi-Vernat S., Ali D., Roubieu C., Durdux C., Laccourreye O., Giraud P. Dysphagia after radiotherapy: state of the art and prevention. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2015, 10.1016/j.anorl.2013.09.006.
71. Popovtzer A., Cao Y., Feng F.Y., Eisbruch A. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study. Radiother. Oncol. 2009, 93:510-515. 10.1016/j.radonc.2009.05.013.
72. Hiss S.G., Postma G.N. Fiberoptic endoscopic evaluation of swallowing. The Laryngoscope 2003, 113:1386-1393. 10.1097/00005537-200308000-00023.
73. Dijkstra P.U., Kalk W.W.I., Roodenburg J.L.N. Trismus in head and neck oncology: a systematic review. Oral Oncol. 2004, 40:879-889. 10.1016/j.oraloncology.2005.09.003.
74. Jensen K., Lambertsen K., Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother. Oncol. 2007, 85:74-82.
75. Eisbruch A., Levendag P.C., Feng F.Y., Teguh D., Lyden T., Schmitz P.I.M., et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int. J. Radiat. Oncol. 2007, 69:S40-S42. 10.1016/j.ijrobp.2007.04.083.
76. Teguh D.N., Levendag P.C., Noever I., van Rooij P., Voet P., van der Est H., et al. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int. J. Radiat. Oncol. 2008, 72:1119-1127. 10.1016/j.ijrobp.2008.02.061.
77. Schwartz D.L., Hutcheson K., Barringer D., Tucker S.L., Kies M., Holsinger F.C., et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int. J. Radiat. Oncol. 2010, 78:1356-1365. 10.1016/j.ijrobp.2009.10.002.
78. Feng F.Y., Kim H.M., Lyden T.H., Haxer M.J., Feng M., Worden F.P., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int. J. Radiat. Oncol. 2007, 68:1289-1298. 10.1016/j.ijrobp.2007.02.049.
79. Sanguineti G., Gunn G.B., Parker B.C., Endres E.J., Zeng J., Fiorino C. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer. Int. J. Radiat. Oncol. 2011, 79:52-59. 10.1016/j.ijrobp.2009.10.057.
80. Levendag P.C., Teguh D.N., Voet P., van der Est H., Noever I., de Kruijf W.J.M., et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother. Oncol. 2007, 85:64-73. 10.1016/j.radonc.2007.07.009.
81. Eisbruch A., Kim H.M., Feng F.Y., Lyden T.H., Haxer M.J., Feng M., et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81:e93-e99. 10.1016/j.ijrobp.2010.12.067.
82. Dornfeld K., Simmons J.R., Karnell L., Karnell M., Funk G., Yao M., et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:750-757.
83. Christianen M.E., Schilstra C., Beetz I., Muijs C.T., Chouvalova O., Burlage F.R., et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother. Oncol. 2012, 105:107-114. 10.1016/j.radonc.2011.08.009.
84. Caudell J.J., Schaner P.E., Desmond R.A., Meredith R.F., Spencer S.A., Bonner J.A. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:403-409.
85. Caglar H.B., Tishler R.B., Othus M., Burke E., Li Y., Goguen L., et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72:1110-1118.
86. Bhide S.A., Gulliford S., Kazi R., El-Hariry I., Newbold K., Harrington K.J., et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother. Oncol. 2009, 93:539-544.
87. Dirix P., Abbeel S., Vanstraelen B., Hermans R., Nuyts S. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int. J. Radiat. Oncol. 2009, 75:385-392. 10.1016/j.ijrobp.2008.11.041.
88. Pauloski B.R., Rademaker A.W., Logemann J.A., Colangelo L.A. Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients. Otolaryngol. Head Neck Surg. 1998, 118:616-624. 10.1016/S0194-5998(98)70230-X.
89. Li B., Li D., Lau D.H., Farwell D.G., Luu Q., Rocke D.M., et al. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat. Oncol. Lond. Engl. 2009, 4:52. 10.1186/1748-717X-4-52.
90. Alterio D., Ciardo D., Preda L., Argenone A., Caspiani O., Micera R., et al. Contouring of the Pharyngeal Superior Constrictor Muscle (PSCM): a cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group. Radiother. Oncol. 2014, 10.1016/j.radonc.2014.05.016.
91. Duprez F., Madani I., De Potter B., Boterberg T., De Neve W. Systematic review of dose-volume correlates for structures related to late swallowing disturbances after radiotherapy for head and neck cancer. Dysphagia 2013, 28:337-349. 10.1007/s00455-013-9452-2.
92. Christianen M.E., Langendijk J.A., Westerlaan H.E., van de Water T.A., Bijl H.P. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother. Oncol. 2011, 101:394-402. 10.1016/j.radonc.2011.05.015.
93. Rancati T., Schwarz M., Allen A.M., Feng F., Popovtzer A., Mittal B., et al. Radiation dose-volume effects in the larynx and pharynx. Int. J. Radiat. Oncol. 2010, 76:S64-S69. 10.1016/j.ijrobp.2009.03.079.
94. Mortensen H.R., Jensen K., Aksglæde K., Behrens M., Grau C. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters. Radiother. Oncol. 2013, 107:288-294. 10.1016/j.radonc.2013.06.001.
95. Anand A.K., Chaudhoory A.R., Shukla A., Negi P.S., Sinha S.N., Babu A.A.G., et al. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer. Br. J. Radiol. 2008, 81:865-871. 10.1259/bjr/31334499.
96. Logemann J.A., Pauloski B.R., Rademaker A.W., Lazarus C.L., Mittal B., Gaziano J., et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 2003, 25:432-437. 10.1002/hed.10255.
97. Pow E.H.N., Kwong D.L.W., McMillan A.S., Wong M.C.M., Sham J.S.T., Leung L.H.T., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int. J. Radiat. Oncol. 2006, 66:981-991. 10.1016/j.ijrobp.2006.06.013.
98. Kam M.K.M., Leung S.-F., Zee B., Chau R.M.C., Suen J.J.S., Mo F., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J. Clin. Oncol. 2007, 25:4873-4879. 10.1200/JCO.2007.11.5501.
99. Tribius S., Sommer J., Prosch C., Bajrovic A., Muenscher A., Blessmann M., et al. Xerostomia after radiotherapy. Strahlenther. Onkol. 2013, 189:216-222. 10.1007/s00066-012-0257-2.
100. Wang Z.-H., Yan C., Zhang Z.-Y., Zhang C.-P., Hu H.-S., Tu W.-Y., et al. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study. Int. J. Radiat. Oncol. 2011, 81:1479-1487. 10.1016/j.ijrobp.2010.07.1990.
101. Strigari L., Benassi M., Arcangeli G., Bruzzaniti V., Giovinazzo G., Marucci L. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy. Int. J. Radiat. Oncol. 2010, 77:269-276. 10.1016/j.ijrobp.2009.07.1734.
102. Murdoch-Kinch C.-A., Kim H.M., Vineberg K.A., Ship J.A., Eisbruch A. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int. J. Radiat. Oncol. 2008, 72:373-382. 10.1016/j.ijrobp.2007.12.033.
103. Jensen S.B., Pedersen A.M.L., Vissink A., Andersen E., Brown C.G., Davies A.N., et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support. Care Cancer 2010, 18:1039-1060. 10.1007/s00520-010-0827-8.
104. Sanguineti G., Endres E.J., Gunn B.G., Parker B. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?. Int. J. Radiat. Oncol. 2006, 66:931-938. 10.1016/j.ijrobp.2006.05.060.
105. Salas S., Deville J.-L., Giorgi R., Pignon T., Bagarry D., Barrau K., et al. Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma. Radiother. Oncol. 2008, 87:195-200. 10.1016/j.radonc.2008.02.011.